NCT07019272 2025-06-13Neratinib in Extended Adjuvant Treatment for HER2+ Early Breast Cancer With pCR But High-Risk Features: A Hebei Multi-Center Real-World StudyHebei Medical University Fourth HospitalNot yet recruiting170 enrolled